Keyphrases
Activated Macrophages
16%
Acute Injury
16%
Alternatively Activated
16%
Arginase-1 (Arg-1)
16%
Biomaterials
16%
Brain Matrix
100%
CD206
16%
Cell-free Approach
16%
Collagen
16%
Cortical Neurons
16%
Decellularized
100%
Decellularized Extracellular Matrix (dECM)
100%
Decellularized Matrix
16%
Decellularized Matrix Hydrogel
16%
Drug-free
16%
Effective Treatment
33%
Engineered Hydrogels
16%
Extracellular Matrix Hydrogel
33%
Functional Improvement
100%
Functional Recovery
33%
Hippocampal Neurons
16%
Inflammatory Macrophages
16%
Inflammatory Process
16%
Injured Spinal Cord
66%
Interleukin-10
16%
Lesion Cavity
16%
Lesion Site
16%
Lesion Size
16%
Locomotor Function
33%
M1 Macrophages
33%
M2 Macrophages
50%
M2 Phase
16%
M2 Phenotype
16%
Macrophage Polarization
100%
Macrophages
50%
Matrix Concentration
16%
Matrix-based
16%
Neurite Outgrowth
16%
Optimal Concentration
16%
Porcine Brain
50%
Primary Macrophages
16%
Primary Neurons
16%
Pro-regenerative
16%
Rat Spinal Cord Injury
100%
Secondary Injury Mechanisms
16%
Spinal Cord
16%
Spinal Cord Compression
16%
Spinal Cord Injury
66%
Spinal Cord Injury Model
33%
Therapeutic Potential
16%
Treatment Options
33%
Wound Healing
16%
Wound Regeneration
16%
Neuroscience
Anti-Inflammatory
9%
Blood Brain Barrier
9%
Extracellular Matrix
72%
Interleukin 10
9%
Macrophage
100%
Neurite Outgrowth
9%
Spinal Cord Injury
100%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
14%
Biomaterial
14%
Blood-Brain Barrier
14%
Inflammation
14%
Injury
42%
Interleukin 10
14%
Pig
42%
Spinal Cord Injury
100%
Wound Healing
28%